X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
Other Listed Suppliers
0
0
1. Foy
2. Gabexate
3. Gabexate Mesilate
4. Gabexate Methanesulfonate
5. Gabexate Monomethanesulfonate
6. Gabexate Monomethanesulfonate, 14c Labeled Cpd
7. Gabexate Monomethanesulfonate, 14c-labeled Cpd
8. Mesilate, Gabexate
9. Mesylate, Gabexate
10. Methanesulfonate, Gabexate
11. Monomethanesulfonate, Gabexate
1. 56974-61-9
2. Gabexate Mesilate
3. Gabexate (mesylate)
4. Foy
5. Gabexate Methanesulfonate
6. 56974-61-9 (mesylate)
7. Gabexate Mesilate [jan]
8. Chembl1398351
9. Ncgc00017121-01
10. Ethyl 4-((6-guanidinohexanoyl)oxy)benzoate Methanesulfonate
11. Cas-56974-61-9
12. 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]-benzoic Acid Ethyl Ester Mesylate
13. Dsstox_cid_25591
14. Dsstox_rid_80986
15. Dsstox_gsid_45591
16. 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]benzoic Acid Ethyl Ester Mesylate
17. Smr000058918
18. E3q07l0649
19. Sr-01000597763
20. Arodate (tn)
21. Mfcd00210299
22. Gabexatemesylate
23. Cpd000058918
24. Gabexate Mesilate (jp17)
25. Mls001401400
26. Mls002222309
27. Mls006010132
28. Schembl317799
29. Dtxsid0045591
30. Chebi:31641
31. Hms1571i17
32. Hms2051a22
33. Hms2098i17
34. Hms2230m20
35. Hms3268g12
36. Hms3370j02
37. Hms3393a22
38. Hms3412h16
39. Hms3655f19
40. Hms3676h16
41. Hms3715i17
42. Gabexate Mesilate [who-dd]
43. Amy39644
44. Bcp13557
45. Hy-b0385
46. Tox21_110789
47. Ac-467
48. Bdbm50288832
49. Gabexate Methanesulfonate [mi]
50. Akos015889904
51. Akos025402087
52. Tox21_110789_1
53. Ccg-100903
54. Ccg-221008
55. Ks-1203
56. Nc00153
57. Ncgc00025297-04
58. Smr002530330
59. Db-052993
60. Ft-0630694
61. G0464
62. Sw197284-3
63. C75670
64. D01672
65. 492g018
66. A831268
67. Sr-01000597763-1
68. Sr-01000597763-2
69. Q27276838
70. 56974-61-9 39492-01-8(base)
71. Ethyl 4-(6-guanidinohexanoyloxy)benzoate Methanesulfonate
72. Gabexate Mesylate, Analytical Standard, For Drug Analysis
73. 4-[6-(diaminomethylideneamino)-1-oxohexoxy]benzoic Acid Ethyl Ester; Methanesulfonic Acid
74. Ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate;methanesulfonic Acid
75. Ethyl 4-[6-[bis(azanyl)methylideneamino]hexanoyloxy]benzoate; Methanesulfonic Acid
76. Benzoic Acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, Ethyl Ester, Methanesulfonate (1:1)
77. Benzoic Acid, 4-[[6-[(aminoiminomethyl)amino]-1-oxohexyl]oxy]-, Ethylester, Monomethanesulfonate
| Molecular Weight | 417.5 g/mol |
|---|---|
| Molecular Formula | C17H27N3O7S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 11 |
| Exact Mass | 417.15697138 g/mol |
| Monoisotopic Mass | 417.15697138 g/mol |
| Topological Polar Surface Area | 180 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 493 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Serine Proteinase Inhibitors
Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)
Market Place
